FindTrial
Sign In

Dhoomapana therapy for cancers.

Randomized open labelled clinical study to evaluate the efficacy, tolerability and safety of Dhoomapana therapy in patients of Head and Neck cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/012964
Enrollment
60
Registered
2018-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Head and Neck Cancer

Interventions

Intervention1: Dhoompana as an add on with ayurvedic rasayana therapy: Inhalation of medicated fumes obtained by burning of somal (Arsenic Trioxide) along with other herbs and herbomineral formulation

Sponsors

Rasayu Cancer Clinic Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and Female cancer patients suffering from head and neck cancers. 2.Cancer patients refractory to conventional line of treatment. 3. Cancer patients willing to take ayurvedic treatment for management of cancer.

Exclusion criteria

Exclusion criteria: 1. Patients taking conventional anticancer therapies.

Design outcomes

Primary

MeasureTime frame
Health related quality of life as assessed by FACT-GTimepoint: Day0,Day15, Day30,Day60,Day90.—

Secondary

MeasureTime frame
Adverse events monitoring.Timepoint: Baseline (Day0), Day30, Day60, Day90.;Tumor response as assessed radiologically.Timepoint: Baseline (Day0), Day90—

Countries

India

Contacts

Public ContactDr Poonam Birari

Rasayu Cancer Clinic Pune.

poonam.birari84@gmail.com02024537149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026